SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-203858
Filing Date
2023-08-04
Accepted
2023-08-04 16:05:58
Documents
5
Period of Report
2023-09-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A d444568dpre14a.htm PRE 14A 437506
2 GRAPHIC g444568g40g40.jpg GRAPHIC 78447
3 GRAPHIC g444568g41g41.jpg GRAPHIC 70452
4 GRAPHIC g444568g43g04.jpg GRAPHIC 327181
5 GRAPHIC g444568g45z13.jpg GRAPHIC 256196
  Complete submission text file 0001193125-23-203858.txt   1447558
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: PRE 14A | Act: 34 | File No.: 001-36830 | Film No.: 231144004
SIC: 2834 Pharmaceutical Preparations